node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
Bcl2 | Nr4a1 | MGP_SPRETEiJ_P0020392 | MGP_SPRETEiJ_P0041746 | B cell leukemia/lymphoma 2. | Nuclear receptor subfamily 4, group A, member 1. | 0.994 |
Bcl2 | Nr4a2 | MGP_SPRETEiJ_P0020392 | MGP_SPRETEiJ_P0053858 | B cell leukemia/lymphoma 2. | Nuclear receptor subfamily 4, group A, member 2. | 0.806 |
Bcl2 | Nr4a3 | MGP_SPRETEiJ_P0020392 | MGP_SPRETEiJ_P0064778 | B cell leukemia/lymphoma 2. | Nuclear receptor subfamily 4, group A, member 3. | 0.691 |
Kcna1 | Nr4a3 | MGP_SPRETEiJ_P0079416 | MGP_SPRETEiJ_P0064778 | Potassium voltage-gated channel, shaker-related subfamily, member 1. | Nuclear receptor subfamily 4, group A, member 3. | 0.613 |
Kcna1 | Scn8a | MGP_SPRETEiJ_P0079416 | MGP_SPRETEiJ_P0041715 | Potassium voltage-gated channel, shaker-related subfamily, member 1. | Sodium channel, voltage-gated, type VIII, alpha. | 0.818 |
Kcna1 | Synj1 | MGP_SPRETEiJ_P0079416 | MGP_SPRETEiJ_P0044137 | Potassium voltage-gated channel, shaker-related subfamily, member 1. | Synaptojanin 1. | 0.613 |
Ncor2 | Nr4a1 | MGP_SPRETEiJ_P0073634 | MGP_SPRETEiJ_P0041746 | Nuclear receptor co-repressor 2. | Nuclear receptor subfamily 4, group A, member 1. | 0.818 |
Ncor2 | Nr4a2 | MGP_SPRETEiJ_P0073634 | MGP_SPRETEiJ_P0053858 | Nuclear receptor co-repressor 2. | Nuclear receptor subfamily 4, group A, member 2. | 0.658 |
Ncor2 | Nr4a3 | MGP_SPRETEiJ_P0073634 | MGP_SPRETEiJ_P0064778 | Nuclear receptor co-repressor 2. | Nuclear receptor subfamily 4, group A, member 3. | 0.622 |
Ncor2 | Rxra | MGP_SPRETEiJ_P0073634 | MGP_SPRETEiJ_P0052556 | Nuclear receptor co-repressor 2. | Retinoid X receptor alpha. | 0.959 |
Ncor2 | Rxrb | MGP_SPRETEiJ_P0073634 | MGP_SPRETEiJ_P0046025 | Nuclear receptor co-repressor 2. | Retinoid X receptor beta. | 0.846 |
Ncor2 | Rxrg | MGP_SPRETEiJ_P0073634 | MGP_SPRETEiJ_P0022079 | Nuclear receptor co-repressor 2. | Retinoid X receptor gamma. | 0.914 |
Nr4a1 | Bcl2 | MGP_SPRETEiJ_P0041746 | MGP_SPRETEiJ_P0020392 | Nuclear receptor subfamily 4, group A, member 1. | B cell leukemia/lymphoma 2. | 0.994 |
Nr4a1 | Ncor2 | MGP_SPRETEiJ_P0041746 | MGP_SPRETEiJ_P0073634 | Nuclear receptor subfamily 4, group A, member 1. | Nuclear receptor co-repressor 2. | 0.818 |
Nr4a1 | Nr4a2 | MGP_SPRETEiJ_P0041746 | MGP_SPRETEiJ_P0053858 | Nuclear receptor subfamily 4, group A, member 1. | Nuclear receptor subfamily 4, group A, member 2. | 0.592 |
Nr4a1 | Nr4a3 | MGP_SPRETEiJ_P0041746 | MGP_SPRETEiJ_P0064778 | Nuclear receptor subfamily 4, group A, member 1. | Nuclear receptor subfamily 4, group A, member 3. | 0.746 |
Nr4a1 | Rxra | MGP_SPRETEiJ_P0041746 | MGP_SPRETEiJ_P0052556 | Nuclear receptor subfamily 4, group A, member 1. | Retinoid X receptor alpha. | 0.927 |
Nr4a1 | Rxrb | MGP_SPRETEiJ_P0041746 | MGP_SPRETEiJ_P0046025 | Nuclear receptor subfamily 4, group A, member 1. | Retinoid X receptor beta. | 0.708 |
Nr4a1 | Rxrg | MGP_SPRETEiJ_P0041746 | MGP_SPRETEiJ_P0022079 | Nuclear receptor subfamily 4, group A, member 1. | Retinoid X receptor gamma. | 0.759 |
Nr4a2 | Bcl2 | MGP_SPRETEiJ_P0053858 | MGP_SPRETEiJ_P0020392 | Nuclear receptor subfamily 4, group A, member 2. | B cell leukemia/lymphoma 2. | 0.806 |